CN Patent

CN102438627A — 美洛昔康的新剂型

Assigned to Iceutica Pty Ltd · Expires 2012-05-02 · 14y expired

What this patent protects

本发明涉及使用干磨法制备美洛昔康颗粒的方法以及包含美洛昔康的组合物、使用颗粒形式的美洛昔康和/或组合物制备的药物，并且涉及使用治疗有效量的通过所述药物施用的美洛昔康治疗动物(包括人)的方法。

USPTO Abstract

本发明涉及使用干磨法制备美洛昔康颗粒的方法以及包含美洛昔康的组合物、使用颗粒形式的美洛昔康和/或组合物制备的药物，并且涉及使用治疗有效量的通过所述药物施用的美洛昔康治疗动物(包括人)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102438627A
Jurisdiction
CN
Classification
—
Expires
2012-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Iceutica Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.